Meridia Weight Loss Drug Overview and Claims
The weight-loss pill Meridia has been a huge sales success for Abbott Laboratories, which claims that the drug has been sold to millions of people in 65 countries. Meridia, generic sibutramine, was approved by the FDA (Federal Drug Administration) for Knoll Laboratories in 1997. Abbott Laboratories acquired Knoll in 2001. Meridia is a norepinephrine and serotonin reuptake inhibitor. These two chemicals are believed to affect appetite. Serotonine is a neurotransmitter in the brain associated with calm feelings, and nonepinephrine is a stimulant. The Meridia claim is that it produces weight loss by acting on the appetite control centers in the brain.
The FDA has required Abbott to include warnings on packaging and education programs about the risk of cardiovascular problems in people taking Meridia for weight loss. See Drug Warnings: Meridia Side Effects and Risks for information about FDA action.
Check out the following articles for more information about Meridia, filing a Meridia lawsuit and finding a Meridia attorney:
- To find out more about the FDA warning, see Meridia Side Effects and Risks
- For more information about Meridia side effects, see Meridia Side Effects – Cardiovascular Problems
- For more information about Meridia updates, see Meridia Information and Warnings
- If you would like to learn more about Meridia lawsuits, see Meridia Lawsuits, Litigation & Lawyers
- To learn more about Meridia attorneys and how to find one, see Hiring a Meridia Attorney and Lawyer